Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04145700
Title CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma
Recruitment Suspended
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

synovial sarcoma

Therapies

Docetaxel + Gemcitabine + Ramucirumab

Docetaxel + Gemcitabine

Age Groups: child | adult
Covered Countries USA | ITA | FRA | ESP | DEU | BEL


No variant requirements are available.